Abstract
We used an exome-sequencing strategy and identified an allelic series of NOTCH2 mutations in Hajdu-Cheney syndrome, an autosomal dominant multisystem disorder characterized by severe and progressive bone loss. The Hajdu-Cheney syndrome mutations are predicted to lead to the premature truncation of NOTCH2 with either disruption or loss of the C-terminal proline-glutamate-serine-threonine-rich proteolytic recognition sequence, the absence of which has previously been shown to increase Notch signaling.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brennan, A.M. & Pauli, R.M. Am. J. Med. Genet. 100, 292–310 (2001).
Ralston, S.H. & Uitterlinden, A.G. Endocr. Rev. 31, 1–24 (2010).
Albano, L.M. et al. Clin. Dysmorphol. 16, 27–33 (2007).
Ostergaard, P. et al. J. Med. Genet. published online, doi:10.1136/jmg.2010.085563 (25 January 2011).
Zanotti, S. & Canalis, E. Mol. Cell. Biol. 30, 886–896 (2010).
Kopan, R. et al. Cell 137, 216–233 (2009).
Rechsteiner, M. & Rogers, S.W. Trends Biochem. Sci. 21, 267–271 (1996).
Nagy, E. & Maquat, L.E. Trends Biochem. Sci. 23, 198–199 (1998).
Lee, S. et al. Cancer Sci. 100, 920–926 (2009).
Weng, A.P. et al. Science 306, 269–271 (2004).
McDaniell, R. et al. Am. J. Hum. Genet. 79, 169–173 (2006).
Morrissette, J.D., Colliton, R.P. & Spinner, N.B. Hum. Mol. Genet. 10, 405–413 (2001).
Hamada, Y. et al. Development 126, 3415–3424 (1999).
Fukushima, H. et al. Mol. Cell. Biol. 28, 6402–6412 (2008).
Kung, A.W.C. et al. Am. J. Hum. Genet. 86, 1–11 (2010).
Acknowledgements
The authors thank the families for participating in this study. This work was supported by grants from the British Heart Foundation (BHF) to R.C.T. and from Cure Kids New Zealand to S.P.R. and M.J.G. The authors also acknowledge support from the UK Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's and St. Thomas' National Health Service (NHS) Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust. Grateful acknowledgment is also made to I. Marik, Chief of the Centre for Patients with Locomotor Defects, Prague, Czech Republic for assistance in recruitment to this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Methods, Supplementary Tables 1–3 and Supplementary Figures 1–3. (PDF 595 kb)
Rights and permissions
About this article
Cite this article
Simpson, M., Irving, M., Asilmaz, E. et al. Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss. Nat Genet 43, 303–305 (2011). https://doi.org/10.1038/ng.779
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.779
This article is cited by
-
Exploratory use of romosozumab for osteoporosis in a patient with Hajdu–Cheney syndrome: a case report
Osteoporosis International (2023)
-
Notch signaling pathway: architecture, disease, and therapeutics
Signal Transduction and Targeted Therapy (2022)
-
Deletion of RBP-Jkappa gene in mesenchymal cells causes rickets like symptoms in the mouse
Current Medicine (2022)
-
Skeletal characterization in a patient with Hajdu-Cheney syndrome undergoing total knee arthroplasty
Osteoporosis International (2021)
-
Cortical bone development, maintenance and porosity: genetic alterations in humans and mice influencing chondrocytes, osteoclasts, osteoblasts and osteocytes
Cellular and Molecular Life Sciences (2021)